Fingerprint
Dive into the research topics of 'Ensartinib (X-396) in ALK-positive non–small cell lung cancer: Results from a first-in-human phase I/II, multicenter study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ensartinib (X-396) in ALK-positive non–small cell lung cancer: Results from a first-in-human phase I/II, multicenter study
Leora Horn, Jeffrey R. Infante, Karen L. Reckamp, George R. Blumenschein, Ticiana A. Leal, Saiama N. Waqar, Barbara J. Gitlitz, Rachel E. Sanborn, Jennifer G. Whisenant, Liping Du, Joel W. Neal, Jon P. Gockerman, Gary Dukart, Kimberly Harrow, Chris Liang, James J. Gibbons, Allison Holzhausen, Christine M. Lovly, Heather A. Wakelee
Research output: Contribution to journal › Article › peer-review
149
Scopus
citations